A Physical Activity Program in End-state Liver Disease
- Conditions
- Liver TransplantSarcopeniaEnd-stage Liver Disease (ESLD)Poor Physical FitnessCirrhosisPortal Hypertension
- Interventions
- Other: Nutritional consultationBehavioral: Physical training programBehavioral: Behavioral modification therapy
- Registration Number
- NCT02776553
- Lead Sponsor
- University of Arkansas
- Brief Summary
The primary aim of this study is to improve both physical fitness and sarcopenia of patients with ESLD who are potentially eligible for liver transplantation through a 12-week physical training program. Secondary aims will focus on changes in anthropometrics, body composition, quality of life, and metabolic profile. This is a randomized clinical trial including 50 patients, with half allocated to the active group (physical training program) and half to standard of care.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
-
Age 40 to 70.
-
Cirrhosis, any cause, defined as:
- Biopsy-proven.
- Two or more of the following: albumin <3.5 g/dL, International Normalized Ration (INR) >1.3, radiologic or endoscopic evidence of portal hypertension.
-
Creatinine <2.0 mg/dL.
-
Physiologic Model for End Stage Liver Disease (MELD) ≥10.
-
Decompensated cirrhosis with active or history of variceal bleeding, ascites, hepatic encephalopathy, or jaundice.
-
Potential transplant candidate as per UAMS criteria
- Large gastric or esophageal varices with contraindication to use beta-blockers.
- Persistent hepatic encephalopathy grades 2-4.
- Prior diagnosis of hepatocellular carcinoma, or hepatic hydrothorax (with prior repeated thoracocentesis).
- Cirrhotic cardiomyopathy or congestive heart failure, pulmonary vascular complications, known active coronary artery disease, syncope, and cardiac dysrhythmias.
- Physical impediment to perform a cardiorespiratory fitness test.
- Use of implantable defibrillator or a pacemaker.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Nutritional consultation nutritional intervention Active (physical training program) Nutritional consultation physical activity + behavioral therapy + nutritional intervention Active (physical training program) Behavioral modification therapy physical activity + behavioral therapy + nutritional intervention Active (physical training program) Physical training program physical activity + behavioral therapy + nutritional intervention
- Primary Outcome Measures
Name Time Method Sarcopenia Change from Baseline to 12 weeks after baseline Total thigh muscle volume (cm\^3), as determined by CT-scan.
Physical Fitness - Distance Walked Change from Baseline to 12 weeks after baseline Total distance walked during 6-minute walk test
Physical Fitness - VO2 Change from Baseline to 12 weeks after baseline Peak VO2 will be obtained from cardiorespiratory stress test
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Arkansas for Medical Sciences
🇺🇸Little Rock, Arkansas, United States